16/08/2001 (Agence Europe) - The Sueddeutsche Zeitung claims that the European Agency for the Evaluation of Medicines was aware if the risks presented by Lipbay/Baycol, anti-cholesterol product withdrawn from the market by Bayer as it was said to be at the origin of the death of some fifty people (see EUROPE of 10 August, p.2 on the Commission's reaction, which said it was following this affair, but that it concerned a medicine having been the subject of national authorisations, and not...